Grifols SA A (EUR)
GRF
Overview
Key Information
Legal Documents
Financials

Overview

SectorHealthcare
Industry-
Day Range29.13 | 30.08
52-Wk Range |
Last Close29.68
Mkt Cap (m)17,494.35
Dividend yield1.16%
ISINES0171996087
Volume533,225
Exchange VenueXMAD

Company Profile

Grifols SA is a pharmaceutical company. It primarily collects the liquid portion of human blood called plasma and then manufactures and sells plasma-derived products globally. It also operates diagnostics, hospital supplies, and raw materials businesses.

Key Information
Price/Earning32.62
Price/Book4.23
Price/Sales3.99
P/CF35.74
Rev Growth (3 year avg)-
EPS Growth (3 year avg)-
Operating Margin % -
Net Margin %-
Return on Equity-
Debt/Equity-

Documents

Prospectus
en 23/04/2015
Annual Report
en 31/12/2019

Financials

Income Statement
EUR201420152016201720182019
Revenue (m)3,3553,9354,0504,3184,487-
Operating Income (m)8589709391,003994-
Net Income (m)470532545663597-
Basic EPS0.690.780.800.970.87-
Avg. Diluted Shares Outstanding (m)685686684684685-
Balance Sheet
EUR201420152016201720182019
Current Assets (m)2,9133,0893,1232,9453,483-
Non Current Assets (m)5,5376,5127,0077,9758,994-
Total Assets (m)8,4509,60210,13010,92012,477-
Current Liabilities (m)1,0801,0531,0729781,257-
Total Liabilities (m)------
Total Equity (m)2,6583,2963,7213,6294,226-
Cash Flows
EUR201420152016201720182019
Operating Cash Flows (m)979743553842737-
Capital Expenditure (m)-287-567-293-323-308-
Figures are quoted in EUR unless stated otherwise
-
No change
29.68
Last Price